Art Van Zee warns Purdue about OxyContin abuse

Art Van Zee’s warnings to Purdue Pharma in 2000 brought evidence of OxyContin misuse among young people to the company’s attention and framed the affected communities as possible early-warning sites. The letters followed complaints from his medical partner about children crushing, snorting, and injecting the drug, and Van Zee continued raising similar concerns as the crisis’s local signs challenged the assumption that heroin and opioid problems belonged elsewhere.

A crisis treated as invisible

Before the Roanoke weathermen incident drew wider attention, heroin in the city was commonly understood as an inner-city, predominantly Black drug. Don Wolthuis, a federal prosecutor, recalled a small and largely isolated population of users in the 1980s and 1990s. That perception helped make the developing problem easy to overlook; it also formed the backdrop to Van Zee’s later warnings about harm emerging in communities not generally associated with heroin use.

The evidence Van Zee and his medical partner encountered concerned young people misusing OxyContin. Dr. Vince Stravino had already filed official complaints that children in the area were crushing, snorting, and injecting the medication, and that some arrived at the hospital with overdoses and abscesses associated with injection. Purdue’s associate medical director, Mayra Ballina, referred to those complaints in a company response written on May 8, 2000.

Letters to Purdue

On August 20, 2000, Van Zee wrote to Dr. J. David Haddox about the extent and prevalence of the problem. The letter carried local clinical observations beyond the hospital: misuse was not merely a hypothetical risk attached to the medicine but conduct already being reported among children in the area, with serious medical consequences.

Van Zee wrote again on November 23, this time to Dr. Daniel Spyker, Purdue’s senior medical director. He warned that the places experiencing these problems might serve as sentinel areas—early indicators of danger that could appear elsewhere. The point of the warning was therefore larger than documenting isolated cases: local evidence, if taken seriously, could help identify a spreading problem before it was dismissed as exceptional.

Persistence and limits of the record

The warnings did not end with the two letters. Van Zee continued to press similar concerns, as accounts of his correspondence and later interviews attest. The surviving evidence establishes that he raised the issue with Purdue officials and that reports of misuse had already reached the company through his medical partner. It does not, by itself, establish what actions Purdue took in response to Van Zee’s letters or whether they changed the company’s conduct.

The episode sits within a wider account of institutional gaps around the opioid crisis. Families and caregivers often struggled to make harms visible while shame and divisions between health care and criminal justice left problems unaddressed. Against that background, Van Zee’s letters function as a record of warning: the signs were present in particular communities, and he urged Purdue to recognize their possible significance before they could be treated as isolated local failures.